Skip to main content
letter
. 2019 Aug 26;34(11):2348–2350. doi: 10.1007/s11606-019-05113-4

Table 1.

Characteristics of 1726 Patients with eGFR-Based CKD Who Have Active PCP Follow-up by Patient Language Preference

Non-English English Total p value
No. (%) No. (%) No. (%)
n = 287 n = 1439 n = 1726
Demographic characteristics
  Age < 0.001
    22–64 33 (12%) 571 (40%) 604 (35%)
    65–74 106 (37%) 601 (42%) 707 (41%)
    75–80 148 (52%) 267 (19%) 415 (24%)
  Male 125 (44%) 762 (53%) 887 (51%) 0.004
  Race/ethnicity < 0.001
    White 34 (12%) 754 (52%) 788 (46%)
    Asian/API 178 (62%) 266 (19%) 444 (26%)
    Black 2 (1%) 239 (17%) 241 (14%)
    Hisp/Latino 38 (13%) 90 (6%) 128 (7%)
    Other 35 (12%) 90 (6%) 125 (7%)
Comorbidities
  Cerebrovascular disease 46 (16%) 166 (12%) 212 (12%) 0.03
  Congestive heart failure 34 (12%) 134 (9%) 168 (10%) 0.19
  Coronary artery disease 80 (28%) 304 (21%) 384 (22%) 0.01
  Diabetes mellitus 163 (57%) 540 (38%) 703 (41%) < 0.001
  Hyperlipidemia 213 (74%) 970 (67%) 1183 (69%) 0.02
  Hypertension 255 (89%) 1144 (80%) 1399 (81%) < 0.001
Insurance
  Insurance type < 0.001
    Medicare 220 (77%) 817 (57%) 1037 (60%)
    MedicareAdv/private 30 (11%) 460 (32%) 490 (28%)
    Medicaid/Medi-cal 36 (13%) 143 (10%) 179 (10%)
    Self-pay/CoveredCA 1 (0%) 19 (1%) 20 (1%)
Care utilization
  PC visits < 0.001
    1–4 49 (17%) 523 (36%) 572 (33%)
    5–6 55 (19%) 254 (18%) 309 (18%)
    7–9 103 (36%) 363 (25%) 466 (27%)
    > 10 80 (28%) 299 (21%) 379 (22%)
CKD stage
  eGFR 0.80
    15–29.99 22 (8%) 128 (9%) 150 (9%)
    30–44.99 61 (21%) 298 (21%) 359 (21%)
    45–59.99 204 (71%) 1013 (70%) 1217 (71%)